Obamacare’s insurers struggle for stability amid Trump threats
Obamacare is stuck in limbo, and insurers and state regulators are struggling to set their plans for what’s increasingly shaping up as a chaotic year for the health-care program.
Obamacare is stuck in limbo, and insurers and state regulators are struggling to set their plans for what’s increasingly shaping up as a chaotic year for the health-care program.
Eli Lilly and Co. told a federal jury that a German company is trying to take credit for centuries-old Chinese medicine in seeking royalties on the use of its erectile-dysfunction drug Cialis to treat an enlarged prostate.
News that federal regulators rejected Lilly’s drug for arthritis sent the stock tumbling more than 5 percent Monday, and sent surprised analysts searching for answers.
The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.
The White House remained mum on the biggest concern. Insurers, doctors, hospitals and the business community have asked President Trump to preserve cost-sharing subsidies that pare down high deductibles and copayments for consumers with modest incomes.
The money, provided to the workforce initiative Ascend Indiana, will train up to 50 specialists a year targeting Indiana's growing opioid epidemic.
A proposed $1 per-pack hike in Indiana's cigarette tax appears likely to fail for a second straight year, dismaying public health advocates.
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
The state Senate approved the measure Thursday by a 32-16 vote after lengthy discussion about needle exchanges, which aim to reduce the spread of infectious diseases by providing people with clean syringes and discouraging needle sharing
Almost half of graduating students in Marian University’s novice College of Osteopathic Medicine are choosing to serve residencies in family medicine.
In the latest sign of health care consolidation, Indiana’s largest independent physician group has agreed to be acquired by the nation’s largest health insurer for $184 million.
A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.
Republicans entertained a fresh White House offer to revise the party's failed health care bill Tuesday as the GOP tried to resuscitate the measure that crashed less than two weeks ago.
Indianapolis-based software company Greenlight.guru has moved operations from one downtown facility to another to accommodate expansion.
An exit by Indianapolis-based Anthem Inc. could be devastating to the health care law, limiting coverage options for consumers.
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
An Indiana Senate panel on Thursday advanced a two-year state budget plan with significant differences in funding for roads, entrepreneurship and education from the House’s plan.
Insurers are using cell phone location data to deny property claims by casting doubt that customers were where they said they were. Experts disagree about the accuracy of such investigations.
Two key Indiana lawmakers said they do not intend to take action on legislation addressing so-called abortion reversal procedures, likely dooming its chances of becoming law this session.